Nigeria

BMI View: It is in the interest of local and multinational drugmakers to assist African markets in the field of pharmacovigilance (PV). Unfortunately, while PV systems are important... 2012-05-09

BMI View: Though progress has been made in fighting the prevalence of counterfeit drugs in Nigeria, more could be done from a legislative point of view such as introducing harsher penalties... 2012-02-23

BMI View: The problems within the National Health Insurance System (NHIS) are typical of the Nigerian business environment. Corruption is endemic and the failure of civil servants across... 2012-02-20

BMI View: We believe claims about a 50% increase in basic pharmaceutical prices in Nigeria are overblown and sensationalised to further politicise the explosive issue of fuel price... 2012-01-16

BMI View: Adcock Ingram's strategy to expand in Sub-Saharan Africa is going to be a big generator of wealth for the company's future, but it has been slow to expand in the region compared... 2011-10-21

BMI View: China's soft power in the African healthcare sector will become increasingly commercialised as its investment in Africa continues to promote sustainability over aid dependence.... 2011-10-14

BMI View: Uncompetitive local drugmakers in Nigeria can only survive with government intervention or investment. This help has come in the form of the Nigerian Pharmaceutical Development... 2011-08-09

BMI View: Healthcare professionals work as a team and, in order to achieve the best clinical results, should be represented by all strata of that team in the management structure. If... 2011-07-26

BMI View: Uncompetitive local drugmakers in Nigeria can only survive with government intervention or investment. This help has come in the form of the Nigerian Pharmaceutical Development... 2011-04-20

BMI View: Uncompetitive local drugmakers in Zimbabwe and Nigeria can only survive with government intervention or foreign direct investment (FDI). This help needs to come in the form... 2011-02-28